JAX Product Spotlight: NSG-FLT3-IL15 (stock #037322)

Optimize the efficacy and safety of your NK cell-based therapeutics using our newest immune humanized NSG variant. The CD34+ humanized NSG-FLT3-IL15 mouse supports the development and maturation of natural killer cells and key immune cell populations, providing a reliable and physiologically relevant, in vivo model to test novel NK-based therapeutics.